Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$19.45 - $37.37 $653,831 - $1.26 Million
-33,616 Reduced 42.91%
44,725 $869,000
Q1 2024

May 06, 2024

BUY
$36.08 - $54.3 $2.83 Million - $4.25 Million
78,341 New
78,341 $2.94 Million
Q3 2023

Nov 07, 2023

BUY
$40.86 - $62.98 $140,721 - $216,903
3,444 Added 18.96%
21,604 $891,000
Q2 2023

Aug 08, 2023

BUY
$50.96 - $58.72 $925,433 - $1.07 Million
18,160 New
18,160 $1.01 Million
Q1 2021

May 14, 2021

SELL
$140.25 - $196.86 $1.73 Million - $2.42 Million
-12,318 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$126.47 - $163.7 $1.56 Million - $2.02 Million
12,318 New
12,318 $1.74 Million
Q2 2020

Aug 13, 2020

SELL
$58.39 - $89.31 $40,873 - $62,517
-700 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$51.57 - $106.62 $36,099 - $74,634
700 New
700 $43,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.